InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+16.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Car Bruce. Director active across 3 companies, notably AGIOS PHARMACEUTICALS, INC.. Aggregated, 6 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €938k. Activity tracked since 6 January 2022. The latest transaction was disclosed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Car Bruce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6 of 6 declarations
About Car Bruce
Car Bruce is a declarant associated with Biohaven Ltd. and Agios Pharmaceuticals, INC., where the listed role is Chief Scientific Officer. Across 6 filings in total, the sampled recent filings run from 2022-01-10 to 2026-01-07 and show purchases totaling EUR 938013, with no sales reported.
